The Alzheimer susceptibility gene BIN1 induces isoform-dependent neurotoxicity through early endosome defects

阿尔茨海默病易感基因BIN1通过早期内体缺陷诱导亚型依赖性神经毒性。

阅读:3
作者:Erwan Lambert # ,Orthis Saha # ,Bruna Soares Landeira ,Ana Raquel Melo de Farias ,Xavier Hermant ,Arnaud Carrier ,Alexandre Pelletier ,Johanna Gadaut ,Lindsay Davoine ,Cloé Dupont ,Philippe Amouyel ,Amélie Bonnefond ,Frank Lafont ,Farida Abdelfettah ,Patrik Verstreken ,Julien Chapuis ,Nicolas Barois ,Fabien Delahaye ,Bart Dermaut ,Jean-Charles Lambert ,Marcos R Costa # ,Pierre Dourlen #

Abstract

The Bridging Integrator 1 (BIN1) gene is a major susceptibility gene for Alzheimer's disease (AD). Deciphering its pathophysiological role is challenging due to its numerous isoforms. Here we observed in Drosophila that human BIN1 isoform1 (BIN1iso1) overexpression, contrary to human BIN1 isoform8 (BIN1iso8) and human BIN1 isoform9 (BIN1iso9), induced an accumulation of endosomal vesicles and neurodegeneration. Systematic search for endosome regulators able to prevent BIN1iso1-induced neurodegeneration indicated that a defect at the early endosome level is responsible for the neurodegeneration. In human induced neurons (hiNs) and cerebral organoids, BIN1 knock-out resulted in the narrowing of early endosomes. This phenotype was rescued by BIN1iso1 but not BIN1iso9 expression. Finally, BIN1iso1 overexpression also led to an increase in the size of early endosomes and neurodegeneration in hiNs. Altogether, our data demonstrate that the AD susceptibility gene BIN1, and especially BIN1iso1, contributes to early-endosome size deregulation, which is an early pathophysiological hallmark of AD pathology.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。